Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas
Public ClinicalTrials.gov record NCT01660451. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01660451
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 227 participants
Conditions and interventions
Conditions
Interventions
- Copanlisib (Aliqopa, BAY80-6946) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 18, 2012
- Primary completion
- Jun 21, 2016
- Completion
- May 17, 2023
- Last update posted
- Jul 16, 2024
2012 – 2023
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35213 | — |
| Not listed | Gilbert | Arizona | 85234 | — |
| Not listed | Anaheim | California | 90801 | — |
| Not listed | Aurora | Colorado | 80012 | — |
| Not listed | Englewood | Colorado | 80113 | — |
| Not listed | Fort Collins | Colorado | 80528 | — |
| Not listed | Seattle | Florida | 98101 | — |
| Not listed | Louisville | Kentucky | 40207 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Saint Louis Park | Minnesota | 55426 | — |
| Not listed | Westbury | New York | 11590 | — |
| Not listed | Clinton | North Carolina | 2753 | — |
| Not listed | Canton | Ohio | 44718 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Spokane | Washington | 99208-1129 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01660451, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2024 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01660451 live on ClinicalTrials.gov.